Serotonergic activity and harm avoidance in abstinent drug addicts;Actividad serotonérgica y evitación de daño en adictos abstinentes a drogas

Actas Espanolas de Psiquiatria

Volumn 30, Issue 4, 2002, Pages 241-245

  Gomez Perretta De Mateo C ^a   Portoles Sanz M ^a   Perez Diaz Ma I ^a   Gomez Perretta De Mateo Ma L ^a   Salom Serra, R ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Harm avoidance; Novelty seeking; Serotonergic activity; Substance abuse; Tridimensional personality questionnaire

Indexed keywords

FENFLURAMINE; PROLACTIN;

ABSTINENCE; ADULT; ARTICLE; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG DEPENDENCE; HUMAN; METHODOLOGY; NORMAL HUMAN; PERSONALITY; QUESTIONNAIRE; SEROTONINERGIC SYSTEM; SUBSTANCE ABUSE;

ADULT; FEMALE; FENFLURAMINE; HARM REDUCTION; HUMANS; MALE; PERSONALITY DISORDERS; PERSONALITY INVENTORY; PROLACTIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE-RELATED DISORDERS;

EID: 0036664329     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;3:167-226.
2. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987;44:573-88.
3. Nelson EC, Cloninger CR. The tridimensional personality questionnaire as a predictor of response to nefazodone treatment of depression. J Affect Disord 1995;35:51-7.
4. Nelson EC, Cloninger CR, Pryzbeck TR, Csernansky JG. Platelet serotonergic markers and Tridimensional Personality Questionnaire measures in a clinical sample. Biol Psychiatry 1996;40:271-8.
5. Hansenne M, Pitchot W, Gonzalez Moreno A, Reggers J, Machurot PY, Ansseau M. Harm avoidance dimension of the Tridimensional Personality Questionnaire and serotonin-1A activity in depressed patients. Biol Psychiatry 1997;42:959-61.
6. Hansenne M, Ansseau M. Harm avoidance and serotonin. Biol Psychol 1999;51:77-81.
7. Pfohl B, Black D, Noyes R Jr, Kelley M, Blum N. A test of the tridimensional personality theory: association with diagnosis and platelet imipramine binding in obsessive-compulsive disorder. Biol Psychiatry 1990;28:41-6.
8. Waller DA, Gullion CM, Petty F, Hardy BW, Murdock MV, Rush AJ. Tridimensional Personality Questionnaire and serotonin in bulimia nervosa. Psychiatry Res 1993;48:9-15.
9. Gerra G, Zaimovic A, Timpano M, Zambelli U, Begarani M, Marzocchi GF, et al. Neuroendocrine correlates of temperament traits in abstinent opiate addicts. J Subst Abuse 2000;11:337-54.
10. Bano MD, Agujetas M, López ML, Tena T, Rodríguez A, Lora-Tamayo C, et al. Fluoxetine (FX) efficacy in the treatment of cocaine dependence methadone maintenance patients. Interaction with plasma levels. Actas Esp Psiquiatr 1999;27:321-4.
11. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Third Edition-Revised: DSM-III-R. Washington, DC: American Psychiatric Association; 1987.
12. First MB, Gibbon M, Spitzer RL, Williams JBW. User's guide for the Structured Clinical Interview for DSM-IV for Axis I Disorders-Research Version (SCID-I, Version 2.0, Final Version). February, 1996.
13. McBride PA, Tierney H, DeMeo M, Chen JS, Mann JJ. Effects of age and gender on CNS serotonergic responsivity in normal adults. Biol Psychiatry 1990;27:1143-55.
14. Muldoon MF, Manuck SB, Jansma CL, Moore AL, Perel J, Mann JJ. D,L- Fenfluramine challenge test: experience in nonpatient sample. Biol Psychiatry 1996;39:761-8.
15. Gómez-Perretta C, Pérez C, Portolés M, Salom R. Tridimensional theory of personality: applications to substance abuse disorders. Actas Esp Psiquiatr 2001;29:143-7.
16. Mann J, McBride PA, Brown RP, Linnoila M, Leon AC, DeMeo M, et al. Relationship between central and peripheral serotonin indexes in depressed and suicidal psychiatric inpatients. Arch Gen Psychiatry 1992;49:442-6.
17. Coccaro EF, Kavoussi RJ, Cooper TB, Hauger RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am J Psychiatry 1997;154:1430-5.
18. López-Ibor JJ Jr, Lana F, Saiz Ruiz J. Impulsive suicidal behavior and serotonin. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1990;18:316-25.
19. Halperin JM, Sharma V, Siever LJ, Schwartz ST, Matier K, Wornell G, et al. Serotonergic function in aggressive and nonaggressive boys with attention deficit hyperactivity disorder. Am J Psychiatry 1994;51:243-8.
20. Handelsman L, Kahn RS, Sturiano C, Rinaldi PJ, Gabriel S, Schmeidler JP, et al. Hostility is associated with a heightened prolactin response to meta-chlorophenylpiperazine in abstinent cocaine addicts. Psychiatry Res 1998;80:1-12.
21. Wills TA, Vaccaro D, McNamara G. Novelty seeking, risk taking, and related constructs as predictors of adolescent substance use: an application of Cloninger's theory. J Subst Abuse 1994;6:1-20.
22. Cole DA, Carpentieri S. Social status and the comordibity of child depression and conduct disorder. J Consult Clin Psychol 1990;58:748-57.
23. Lesch KP, Wolozin BL, Murphy DL, Riederer P. Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993;60:2319-22.
24. Cook EH Jr, Fletcher KE, Wainwright M, Marks N, Yan SY, Leventhal BL. Primary structure of the human platelet serotonin 5-HT2A receptor: identity with frontal cortex serotonin 5-HT2A receptor. J Neurochem 1994;63:465-9.